RUTW240806C2280000
- 0.36
- 0.000.00%
Russell 2000 Index Newsroom
Goldman Sachs Upgrades Lumen Technologies to Neutral, Raises Price Target to $4
Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Next Science Ltd (OtherNXSCF)
ACADIA Pharmaceuticals Hold Rating: A Cautious Outlook on Daybue's Market Performance
Barclays Maintains Rapid7(RPD.US) With Hold Rating, Cuts Target Price to $36
KeyBanc Initiates Rapid7(RPD.US) With Hold Rating
Barclays Maintains Beam Therapeutics(BEAM.US) With Hold Rating, Cuts Target Price to $31
Barclays Maintains Upstart(UPST.US) With Hold Rating, Maintains Target Price $25
Barclays Maintains Victoria's Secret(VSCO.US) With Sell Rating, Cuts Target Price to $17
JMP Securities Maintains Dave Inc(DAVE.US) With Buy Rating, Maintains Target Price $75
Barclays Maintains Bloomin Brands(BLMN.US) With Buy Rating, Cuts Target Price to $22
KeyBanc Maintains Atkore(ATKR.US) With Buy Rating, Cuts Target Price to $125
JMP Securities Maintains Shutterstock(SSTK.US) With Hold Rating
Barclays Maintains Jack in the Box(JACK.US) With Hold Rating, Cuts Target Price to $57
JMP Securities Maintains Ares Commercial Real Estate Corp(ACRE.US) With Hold Rating
JMP Securities Maintains Claros Mortgage Trust(CMTG.US) With Hold Rating
KeyBanc Maintains Sunrun(RUN.US) With Hold Rating
JMP Securities Maintains Broadstone Net Lease(BNL.US) With Hold Rating
Barclays Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $30
Barclays Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $14
Barclays Maintains Dine Brands Global Inc(DIN.US) With Buy Rating, Maintains Target Price $54